A Critical Evaluation of PI3K Inhibition in Glioblastoma and Neuroblastoma Therapy

Molecular and Cellular Therapies
doi 10.1186/2052-8426-2-32
Full Text
Abstract

Available in full text

Date
Authors
Publisher

River Publishers

Related search

Design, Synthesis, and Evaluation of Curcumin-Derived Arylheptanoids for Glioblastoma and Neuroblastoma Cytotoxicity

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2013English

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

MIBG in Neuroblastoma Diagnostic Imaging and Therapy

Radiographics
MedicineNuclear MedicineRadiologyImaging
2016English

A Critical Kinase Cascade in Neurological Disorders: PI3K, Akt and mTOR

Future Neurology
Neurology
2012English

Targeted Molecular Therapy in Glioblastoma

Journal of Oncology
Oncology
2020English

FoxO Proteins or Loss of Functional P53 Maintain Stemness of Glioblastoma Stem Cells and Survival After Ionizing Radiation Plus PI3K/mTOR Inhibition

Oncotarget
Oncology
2016English

Inhibition of PI3K and MEK in Combination With Radiation Therapy in Murine Model of Head and Neck Squamous Cell Carcinoma (HNSCC)

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Coordinate Activation of SHH and PI3K Signaling in PTEN-deficient Glioblastoma: New Therapeutic Opportunities

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

Dual PI3K/mTOR Inhibition in Colorectal Cancers withAPCandPIK3CAMutations

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy